CDKN2A and eccrine carcinoma: One other patient had a clear ARID1A loss on IHC: a patient with eccrine adenocarcinoma with ARID1A stop-gain mutation (R693X, resulting in truncated protein expression) and H score of 0 (Figure 3K) with CDKN2A deletion (240 mg BD; SD, 34 weeks).